Rafael (NYSE:RFL) Posts Earnings Results

Rafael (NYSE:RFL) issued its quarterly earnings results on Wednesday. The company reported ($0.19) earnings per share (EPS) for the quarter, Zacks reports. Rafael had a negative return on equity of 53.71% and a negative net margin of 5,707.03%.

Rafael Stock Performance

Shares of RFL stock opened at $2.84 on Wednesday. The stock has a market capitalization of $70.75 million, a price-to-earnings ratio of -1.70 and a beta of 0.91. Rafael has a one year low of $1.28 and a one year high of $3.19. The company’s 50-day simple moving average is $1.58 and its 200-day simple moving average is $1.80.

Insiders Place Their Bets

In other Rafael news, CEO Howard S. Jonas bought 13,080,457 shares of the company’s stock in a transaction on Thursday, June 5th. The shares were bought at an average cost of $1.28 per share, with a total value of $16,742,984.96. Following the completion of the acquisition, the chief executive officer now owns 12,299,207 shares of the company’s stock, valued at approximately $15,742,984.96. This trade represents a -1,674.30% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.20% of the stock is currently owned by company insiders.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.